Video

View G. Steven Burrill's Presentation from BioConference Live
November 17, 2009.

View video 

Podcast

Jerry Flanagan, healthcare policy director for ConsumerWatchdog, discusses his group’s lawsuit against Anthem Blue Cross of California over its rate hikes, what they mean for healthcare reform, and why the proposed healthcare legislation wouldn’t have prevented Anthem from instituting the rate increases in the first place.
Hear the podcast 

G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

News

Biotech posts gain in February as broader markets strengthen March 03, 2010 | Press Release

Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release

Biotech Closes the Year on an Upswing January 04, 2010 | Press Release

  See all News
 
Sign up for a free subscription to The Burrill Weekly Brief 
Sign up to receive email notifications about our upcoming events and news.


Burrill Media is the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publishes a wide range of bio-intelligence reports. Annual conferences include The Biotech Meeting, The Indiana Life Sciences Forum, The Burrill Personalized Medicine Meeting, The Aging Meeting and The Stem Cell Meeting. Burrill Media publications  include the annual State of the Industry, The Personalized Medicine Report, The Stem Cell Report, and periodic newsletters covering Canada, China, Europe, India, Japan and Partnering/M&A. Burrill also publishes The Burrill Report, a monthly digital publication.

Burrill Canadian Biotech Weekly News



The Burrill Canadian Biotech News is a premier weekly biotechnology publication, which has been reporting on the Canadian biotech industry for over 18 years. It is the publication of record for news, events and the capital markets in Canada’s growing biotech and life sciences sectors. Its continuing commitment to an outstanding level of excellence is fueled by founder and Editor-in-Chief, Peter Winter - a bioscientist and award-winning journalist with over 25 years experience of consulting, writing and editing. He is Canada's leading expert and commentator on Canadian biotechnology and his opinions, reports and commentaries are widely sought by government organizations and companies.

A one-year subscription to Canadian Biotech News is US$775.00. Published 46 times per year (double issues in August and December), each issue brings you the latest news and analysis on Canada’s rapidly evolving public and private companies and organizations. Your paid subscription comes with a free copy of Biotech 2009:  Life Sciences: Navigating the Sea Change (a $450 value)

Click to view sample issues:
VOLUME 18 NUMBER 12
VOLUME 18 NUMBER 13
VOLUME 18 NUMBER 14

Click here to subscribe to the Canadian Biotech News.


Add to cart$775.00